Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Shares Outstanding (2020 - 2025)

Biofrontera has reported Shares Outstanding over the past 6 years, most recently at $11.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $11.6 million for Q4 2025, up 31.26% from a year ago — trailing twelve months through Dec 2025 was $11.6 million (up 31.26% YoY), and the annual figure for FY2025 was $11.6 million, up 31.26%.
  • Shares Outstanding for Q4 2025 was $11.6 million at Biofrontera, up from $19881.0 in the prior quarter.
  • Over the last five years, Shares Outstanding for BFRIW hit a ceiling of $11.6 million in Q4 2025 and a floor of $9234.0 in Q2 2025.
  • Median Shares Outstanding over the past 5 years was $1.4 million (2023), compared with a mean of $3.6 million.
  • Biggest five-year swings in Shares Outstanding: soared 799900.0% in 2021 and later plummeted 99.82% in 2025.
  • Biofrontera's Shares Outstanding stood at $855237.0 in 2021, then surged by 56.09% to $1.3 million in 2022, then grew by 13.68% to $1.5 million in 2023, then crashed by 99.33% to $10129.0 in 2024, then soared by 114899.73% to $11.6 million in 2025.
  • The last three reported values for Shares Outstanding were $11.6 million (Q4 2025), $11.6 million (Q3 2025), and $10.1 million (Q2 2025) per Business Quant data.